Ordinary Rebalance | Solactive Future Pharmaceutical Europe Index | Effective Date 7th September 2023
Solactive Future Pharmaceutical Europe Index:
In the ordinary rebalance, the following composition will be implemented effective open 07.09.2023:
| ARGENX SE |
| ASTRAZENECA PLC |
| BAYER AG |
| GENMAB A/S |
| GSK PLC |
| IPSEN SA |
| LONZA GROUP AG |
| MERCK KGAA |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| RECORDATI SPA |
| ROCHE HOLDING AG |
| SANOFI SA |
| SARTORIUS AG PREF |
| UCB SA |